Skip to main content

Table 6 Acute adverse events recorded during concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: gastrointestinal symptoms

From: Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

 

Grade

Nausea/vomiting

Diarrhea

Gastritis

Proctitis

Hematochezia

Highest

Cohort 1

1

3

8

2

2

2

8

2

2

3

0

1

0

3

3

0

1

0

1

0

2

Cohort 2

1

2

7

2

2

1

7

2

3

4

1

1

1

5

 

3

0

1

0

0

0

1